{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T21:33:17Z","timestamp":1774819997176,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Despite adequate glucocorticoid (GC) and mineralocorticoid (MC) replacement therapy, patients suffering from primary adrenal insufficiency (AI) have an increased mortality, mainly due to cardiovascular diseases. Only little knowledge exists on the contribution of MC substitution to the cardiovascular risk. Therefore, this study investigates the impact of plasma renin concentration on parameters of micro- and macrovascular function.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>26 patients with primary AI [female\u2009=\u200918, age: 51 (28; 78) years; BMI: 24 (18; 40) kg\/m<jats:sup>2<\/jats:sup>; disease duration: 18 (5; 36) years] were included in this cross-sectional analysis. Intima media thickness (IMT) and pulse wave velocity (PWV) were investigated to assess macrovascular remodeling and arterial stiffness. Microvascular function was estimated by post-occlusive reactive hyperemia using laser Doppler fluxmetry. Baseline perfusion, biological zero, peak perfusion, time to peak and recovery time were recorded. Patients were grouped according to their median plasma renin concentration of previous visits (Renin<jats:sub>high<\/jats:sub> vs Renin<jats:sub>low<\/jats:sub>) and were compared to a group of healthy women [age: 44 (43; 46) years; BMI: 24.2 (21.8; 27.5)].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>PWV was significantly higher in AI patients compared to controls [9.9 (5; 18.5) vs 7.3 (6.8; 7.7) m\/s; <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.01], whereas no differences in microvascular function could be found. In Renin<jats:sub>low<\/jats:sub> time to peak perfusion was significantly longer [6.0 (3; 15) vs 3.5 (1.5; 11) s; <jats:italic>p<\/jats:italic>\u2009&lt;\u2009.05], whereas no differences in IMT and PWV were observed between Renin<jats:sub>high<\/jats:sub> and Renin<jats:sub>low<\/jats:sub>. No impact of GC dose was observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Microvascular function is not impaired in patients with primary AI under adequate replacement therapy, although higher renin concentrations are associated with subclinical improvements. No relation between RAAS activity and macrovascular function is observed, while arterial stiffness might be increased in primary AI.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-020-01309-2","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T16:03:52Z","timestamp":1591113832000},"page":"339-345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case\u2013control study"],"prefix":"10.1007","volume":"44","author":[{"given":"M.","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Beiglb\u00f6ck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fellinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Winhofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Luger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gschwandtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Willfort-Ehringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Koppensteiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kautzky-Willer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9265-7274","authenticated-orcid":false,"given":"M.","family":"Krebs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Schlager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"1309_CR1","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s40618-019-01079-6","volume":"42","author":"C Betterle","year":"2019","unstructured":"Betterle C, Presotto F, Furmaniak J (2019) Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults. J Endocrinol Investig 42:1407\u20131433","journal-title":"J Endocrinol Investig"},{"key":"1309_CR2","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1210\/jc.2006-0076","volume":"91","author":"R Bergthorsdottir","year":"2006","unstructured":"Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G (2006) Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 91:4849\u20134853","journal-title":"J Clin Endocrinol Metab"},{"key":"1309_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1530\/EJE-07-0455","volume":"157","author":"BR Walker","year":"2007","unstructured":"Walker BR (2007) Glucocorticoids and cardiovascular disease. Eur J Endocrinol Eur Fed Endocr Soc 157:545\u2013559","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"1309_CR4","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1210\/jc.2006-0524","volume":"91","author":"H Filipsson","year":"2006","unstructured":"Filipsson H, Monson JP, Koltowska-Haggstrom M, Mattsson A, Johannsson G (2006) The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 91:3954\u20133961","journal-title":"J Clin Endocrinol Metab"},{"key":"1309_CR5","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1210\/jc.2013-4305","volume":"99","author":"CJ Petersons","year":"2014","unstructured":"Petersons CJ, Mangelsdorf BL, Thompson CH, Burt MG (2014) Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency. J Clin Endocrinol Metab 99:2269\u20132276","journal-title":"J Clin Endocrinol Metab"},{"key":"1309_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","volume":"6","author":"AM Isidori","year":"2018","unstructured":"Isidori AM, Venneri MA, Graziadio C, Simeoli C, Fiore D, Hasenmajer V, Sbardella E, Gianfrilli D, Pozza C, Pasqualetti P, Morrone S, Santoni A, Naro F, Colao A, Pivonello R, Lenzi A (2018) Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. Lancet Diabetes Endocrinol 6:173\u2013185","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1309_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1210\/jc.2011-1926","volume":"97","author":"G Johannsson","year":"2012","unstructured":"Johannsson G, Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engstrom BE, Olsson T, Ragnarsson O, Ryberg M, Wahlberg J, Biller BM, Monson JP, Stewart PM, Lennernas H, Skrtic S (2012) Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab 97:473\u2013481","journal-title":"J Clin Endocrinol Metab"},{"key":"1309_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1530\/EJE-19-0086","volume":"181","author":"P Wolf","year":"2019","unstructured":"Wolf P, Mayr J, Beiglbock H, Fellinger P, Winhofer Y, Poglitsch M, Gessl A, Kautzky-Willer A, Luger A, Krebs M (2019) Identifying a disease-specific renin\u2013angiotensin\u2013aldosterone system fingerprint in patients with primary adrenal insufficiency. Eur J Endocrinol Eur Fed Endocr Soc 181:39\u201344","journal-title":"Eur J Endocrinol Eur Fed Endocr Soc"},{"key":"1309_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12020-019-01974-1","volume":"65","author":"P Wolf","year":"2019","unstructured":"Wolf P, Beiglbock H, Fellinger P, Pfleger L, Aschauer S, Gessl A, Marculescu R, Trattnig S, Kautzky-Willer A, Luger A, Winhofer Y, Krssak M, Krebs M (2019) Plasma renin levels are associated with cardiac function in primary adrenal insufficiency. Endocrine 65:399\u2013407","journal-title":"Endocrine"},{"key":"1309_CR10","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/hy1201.100589","volume":"38","author":"M Ruiz-Ortega","year":"2001","unstructured":"Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza J, Egido J (2001) Role of the renin\u2013angiotensin system in vascular diseases\u2014expanding the field. Hypertension 38:1382\u20131387","journal-title":"Hypertension"},{"key":"1309_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","volume":"6","author":"G Hundemer","year":"2018","unstructured":"Hundemer G, Curhan G, Yozamp N, Wang M, Vaidya A (2018) Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol 6:51\u201359","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1309_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/01.RES.0000052920.70316.AE","volume":"92","author":"MB Taubman","year":"2003","unstructured":"Taubman MB (2003) Angiotensin II: a vasoactive hormone with ever-increasing biological roles. Circ Res 92:9\u201311","journal-title":"Circ Res"},{"key":"1309_CR13","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-12-0341","volume":"216","author":"RA Santos","year":"2013","unstructured":"Santos RA, Ferreira AJ, Verano-Braga T, Bader M (2013) Angiotensin-converting enzyme 2, angiotensin-(1\u20137) and Mas: new players of the renin\u2013angiotensin system. J Endocrinol 216:R1\u2013R17","journal-title":"J Endocrinol"},{"key":"1309_CR14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1161\/CIRCULATIONAHA.107.763730","volume":"118","author":"BI Levy","year":"2008","unstructured":"Levy BI, Schiffrin EL, Mourad JJ, Agostini D, Vicaut E, Safar ME, Struijker-Boudier HA (2008) Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation 118:968\u2013976","journal-title":"Circulation"},{"key":"1309_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1046\/j.1365-2362.2003.01179.x","volume":"33","author":"RG Ijzerman","year":"2003","unstructured":"Ijzerman RG, de Jongh RT, Beijk MAM, van Weissenbruch MM, Delemarre-van de Waal HA, Sern\u00e9 EH, Stehouwer CDA (2003) Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Investig 33:536\u2013542","journal-title":"Eur J Clin Investig"},{"key":"1309_CR16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/254056a0","volume":"254","author":"MD Stern","year":"1975","unstructured":"Stern MD (1975) In vivo evaluation of microcirculation by coherent light scattering. Nature 254:56\u201358","journal-title":"Nature"},{"key":"1309_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.tips.2006.07.008","volume":"27","author":"JL Cracowski","year":"2006","unstructured":"Cracowski JL, Minson CT, Salvat-Melis M, Halliwill JR (2006) Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci 27:503\u2013508","journal-title":"Trends Pharmacol Sci"},{"key":"1309_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.vascn.2004.11.003","volume":"52","author":"GB Yvonne-Tee","year":"2005","unstructured":"Yvonne-Tee GB, Rasool AH, Halim AS, Rahman AR (2005) Reproducibility of different laser Doppler fluximetry parameters of postocclusive reactive hyperemia in human forearm skin. J Pharmacol Toxicol Methods 52:286\u2013292","journal-title":"J Pharmacol Toxicol Methods"},{"key":"1309_CR19","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/ehjci\/jex239","volume":"19","author":"H Sillesen","year":"2018","unstructured":"Sillesen H, Sartori S, Sandholt B, Baber U, Mehran R, Fuster V (2018) Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans. Eur Heart J Cardiovasc Imaging 19:1042\u20131050","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1309_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0021-9150(93)90088-C","volume":"102","author":"M Bats","year":"1993","unstructured":"Bats M, Witteman J, Grobbee D (1993) Carotid intima-media wall thickness in elderly women with and without atherosclerosis of the abdominal aorta. Atherosclerosis 102:99\u2013105","journal-title":"Atherosclerosis"},{"key":"1309_CR21","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","volume":"55","author":"C Vlachopoulos","year":"2010","unstructured":"Vlachopoulos C, Aznaouridis K, Stefanadis C (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 55:1318\u20131327","journal-title":"J Am Coll Cardiol"},{"key":"1309_CR22","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1177\/1479164116683148","volume":"14","author":"S Charwat-Resl","year":"2017","unstructured":"Charwat-Resl S, Yarragudi R, Heimbach M, Leitner K, Leutner M, Gamper J, Giurgea G, Mueller M, Koppensteiner R, Gschwandtner M, Kautzky-Willer A, Schlager O (2017) Microvascular function in women with former gestational diabetes: a cohort study. Diabetes Vasc Dis Res 14:214\u2013220","journal-title":"Diabetes Vasc Dis Res"},{"key":"1309_CR23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s40618-019-01146-y","volume":"43","author":"AM Isidori","year":"2020","unstructured":"Isidori AM, Arnaldi G, Boscaro M, Falorni A, Giordano C, Giordano R, Pivonello R, Pozza C, Sbardella E, Simeoli C, Scaroni C, Lenzi A, Italian Society of E (2020) Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion. J Endocrinol Investig 43:683\u2013696","journal-title":"J Endocrinol Investig"},{"key":"1309_CR24","first-page":"2601","volume":"1842","author":"B Schmitz","year":"2014","unstructured":"Schmitz B, Brand SM, Brand E (2014) Aldosterone signaling and soluble adenylyl cyclase\u2014a nexus for the kidney and vascular endothelium. Biochem Biophys Acta 1842:2601\u20132609","journal-title":"Biochem Biophys Acta"},{"key":"1309_CR25","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.jacc.2016.11.064","volume":"69","author":"R Basu","year":"2017","unstructured":"Basu R, Poglitsch M, Yogasundaram H, Thomas J, Rowe BH, Oudit GY (2017) Roles of angiotensin peptides and recombinant human ACE2 in heart failure. J Am Coll Cardiol 69:805\u2013819","journal-title":"J Am Coll Cardiol"},{"key":"1309_CR26","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ (2016) Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:364\u2013389","journal-title":"J Clin Endocrinol Metab"},{"key":"1309_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1210\/jc.2017-01928","volume":"103","author":"D Esposito","year":"2018","unstructured":"Esposito D, Pasquali D, Johannsson G (2018) Primary adrenal insufficiency: managing mineralocorticoid replacement therapy. J Clin Endocrinol Metab 103:376\u2013387","journal-title":"J Clin Endocrinol Metab"},{"key":"1309_CR28","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1210\/jc.2009-1368","volume":"94","author":"MM Erichsen","year":"2009","unstructured":"Erichsen MM, L\u00f8v\u00e5s K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES (2009) Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian Registry. J Clin Endocrinol Metab 94:4882\u20134890","journal-title":"J Clin Endocrinol Metab"},{"key":"1309_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1055\/s-0031-1295460","volume":"44","author":"M Stowasser","year":"2012","unstructured":"Stowasser M, Ahmed AH, Pimenta E, Taylor PJ, Gordon RD (2012) Factors affecting the aldosterone\/renin ratio. Horm Metab Res 44:170\u2013176","journal-title":"Horm Metab Res"},{"key":"1309_CR30","first-page":"dgz055","volume":"105","author":"R Pofi","year":"2019","unstructured":"Pofi R, Prete A, Thornton-Jones V, Bryce J, Ali SR, Faisal Ahmed S, Balsamo A, Baronio F, Cannuccia A, Guven A, Guran T, Darendeliler F, Higham C, Bonfig W, de Vries L, Bachega T, Miranda MC, Mendonca BB, Iotova V, Korbonits M, Krone NP, Krone R, Lenzi A, Arlt W, Ross RJ, Isidori AM, Tomlinson JW (2019) Plasma renin measurements are unrelated to mineralocorticoid replacement dose in patients with primary adrenal insufficiency. J Clin Endocrinol Metab 105:dgz055","journal-title":"J Clin Endocrinol Metab"},{"key":"1309_CR31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/jch.13167","volume":"20","author":"A Diaz","year":"2018","unstructured":"Diaz A, Tringler M, Wray S, Ramirez AJ, Cabrera Fischer EI (2018) The effects of age on pulse wave velocity in untreated hypertension. J Clin Hypertens (Greenwich) 20:258\u2013265","journal-title":"J Clin Hypertens (Greenwich)"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01309-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01309-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01309-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T04:58:26Z","timestamp":1622523506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01309-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1309"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01309-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"17 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No author has to report a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All study related activities were approved by the ethical committe of the Medical University of Vienna, Vienna, Austria","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}